Post-COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective

Jessica Williams1, Emma Meadows2, Manrita Singh3

  • 1Department of Molecular Imaging, HCA Healthcare UK, London, England; and jess_williams@mac.com.

Insights

The COVID-19 pandemic necessitates updated molecular imaging protocols. Proper preparation can minimize contamination risks and maintain departmental capacity during future waves.

Area of Science:

  • Medical imaging
  • Radiology
  • Healthcare management

Background:

  • The COVID-19 pandemic has significantly impacted global healthcare systems and patient care.
  • Varied international guidance exists for managing patients potentially infected with SARS-CoV-2.
  • A second wave of the pandemic poses a continued risk, highlighting the need for adaptive strategies.

Purpose of the Study:

  • To outline essential precautions for molecular imaging departments to minimize exposure and contamination risks.
  • To provide a UK-specific perspective on managing potential COVID-19 cases within these departments.
  • To ensure molecular imaging departments can operate at full capacity despite pandemic challenges.

Main Methods:

  • Review of current molecular imaging departmental workflows.
  • Analysis of infection control guidelines relevant to healthcare settings.
  • Adaptation of protocols for patient screening and management within imaging departments.

Main Results:

  • Implementation of specific protocols can significantly reduce the risk of viral transmission.
  • Standardized procedures enhance patient and staff safety.
  • Proactive planning allows for sustained operational capacity.

Conclusions:

  • Adopting stringent safety measures is crucial for molecular imaging departments during the COVID-19 pandemic.
  • Learning from initial responses and implementing UK-based strategies can mitigate risks.
  • Preparedness is key to maintaining essential healthcare services amidst global health crises.

Related Concept Videos